Rare diseases (less than 5 in 10,000 people affected) are at a level of 7,000 to 8,000, of which 80% with a genetic etiology. Recognized as a public health priority by the French government since 2005, rare diseases affect about 3 million individuals in France.
However, despite recent successes in diagnosis, care or therapeutic development, 50% of patients are still without any molecular diagnosis and effective treatment exists for only 5% of cases. The objective of the MarMaRa institute is to gather research laboratories, medical teams, educational teams and industrial partners around cross-cutting actions to develop cutting-edge research for the benefit of patients. By federating new stakeholders, the MarMaRa institute aims at promoting, at the local, national and international levels, multidisciplinary research and training in connection with the socio-economic and cultural environment in the field of rare diseases.
Aix-Marseille University, Inserm, Faculty of Medical and Paramedical Sciences
Marseille-Timone Campus | Laboratory UMR 1251
Medical Genetics Center of Marseille
27 Boulevard Jean Moulin
13385 Marseille, cedex 05 | FRANCE